£585 / $1025 / €735
On-line
Monitoring world cardiovascular drug markets is becoming more and more vital as heart disease, in all its guises, remains one of the most prevalent conditions. And that is where Cardiovascular Drug News (CVDN) comes in.
CVDN monitors the companies, products, strategic alliances and research developments that are shaping global cardiovascular markets. Incorporating primary source material augmented with data from Espicom's unique intelligence database, CVDN provides a compelling, easy-to-read route to complete market knowledge.
Whether your interest is commercial, financial or scientific, no other business publication comes close to providing such a comprehensive overview of developments in every area of cardiovascular drug development.
Areas covered by CVDN:
Cost-effective multi-user distribution deals means the service can be used widely by colleagues in your organisation – contact direct_sales@espicom.com for details, alternatively you can use our contact us page.